Fennell, Dean A <br/><br/>
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Feb 2005 
 - 277-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0169-5002 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2004.08.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Disease Progression<br/>Female<br/>Humans<br/>Male<br/>Mesothelioma--drug therapy<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Pleural Neoplasms--drug therapy<br/>Survival Analysis<br/>Treatment Outcome<br/>Vinblastine--administration & dosage<br/>Vinorelbine